Mesenchymal stem cell model with loss of RAP1 function and preparation method and application thereof
A cell model and pluripotent stem cell technology, applied in the field of human mesenchymal stem cell model and its preparation, can solve problems such as over-activation of telomerase and carcinogenesis, and achieve the effects of delaying the aging process, improving cell proliferation, and prolonging telomere length.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0083] Example 1. Construction and Identification of Embryonic Stem Cell Lines with Loss of RAP1 Function
[0084] This example relates to the targeted inactivation of the human RAP1 gene in human embryonic stem cells (genome sequence is GenBank: NC_000016.10 at position 75,647,737-75,657,442, updated on PRI 12-JUL-2017; cDNA sequence is GenBank: NM_018975.3, updated on PRI 10-JUL-2017), the function of RAP1 protein was lost, and human embryonic stem cells with loss of RAP1 function were obtained.
[0085] The present invention firstly designs and obtains homology arm sequences targeting both sides of exon 2 of the RAP1 gene in the human genome through a molecular cloning method, and then constructs them on the pCR2.1-neo vector to obtain the RAP1 homology arm vector. Then construct a gRNA vector targeting exon 2 of the RAP1 gene (product of Addgene Company, trade name and catalog number are gRNA Cloning Vector, Plasmid #41824). Finally, the RAP1 homology arm vector, gRNA exp...
Embodiment 2
[0137] Example 2, RAP1 - / - Directed differentiation of hESC in vitro to produce RAP1 - / - hMSC and RAP1 - / - hMSC phenotyping
[0138] In this embodiment, the RAP1 obtained in Example 1 - / - hESC were further differentiated into mesenchymal stem cells in vitro (RAP1 - / - hMSC), and found that RAP1 - / - hMSCs can delay the aging phenotype to a certain extent.
[0139] 1. RAP1 - / - Directed differentiation of hESC in vitro to produce RAP1 - / - hMSC
[0140] RAP1 - / - The hESCs were differentiated into embryoid bodies (EBs) and differentiated for 48-72 hours to obtain embryoid bodies (EBs). Then, the EBs were inoculated into 6-well plates coated with Matrigel (Invitrogen Company) for culture, and continued to culture for 2 weeks until fibrous cells appeared. After another passaging, the cell populations in which CD73, CD90 and CD105 were all positive were sorted by flow cytometry ( figure 2 Middle A), that is, loss of RAP1 function (RAP1 - / - ) human mesenchymal stem cells (d...
Embodiment 3
[0177] Example 3, RAP1 - / - Detection of hMSC Telomere Length
[0178] 1. Use Southern blotting to analyze the length of telomere restriction fragments
[0179] To investigate whether RAP1 loss-of-function affects changes in telomere length, RAP1 + / + hMSC (wild type) and RAP1 - / - hMSC cells (passages P2 and P9) were the test cells. They were normally cultured and digested to collect the cells. The complete genomic DNA was extracted and the relative length of telomere restriction fragments was analyzed by Southern blotting. Specific steps are as follows:
[0180] 1) Digest and collect cells, centrifuge at 1000 rpm for 5 minutes;
[0181] 2) Wash once with PBS, use the salting-out method DNA extraction kit (product of Meiji Company, article number: D3313-01) to extract the genomic DNA of the test cells, and obtain a large amount of complete genomic DNA;
[0182] 3) Use HinfⅠ (product of NEB Company, product number: R0155) and RsaⅠ (product of NEB Company, product number: R01...
PUM
Property | Measurement | Unit |
---|---|---|
Molecular weight | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
![application no application](https://static-eureka.patsnap.com/ssr/23.2.0/_nuxt/application.06fe782c.png)
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap